EUVIMEDEUVIMED entdecken
Crossref

Anxiogenic-like effects of coumarin, possibly through the GABAkine interaction pathway: Animal studies with in silico approaches

Abdullah Al Shamsh Prottay, Emamuzzaman, Tawfik Rakaiyat Ripu, Md Nazim Sarwar, Towfiqur Rahman, Md Shakil Ahmmed, Mehedi Hasan Bappi, Md Emon, Siddique Akber Ansari, Henrique D M Coutinho, Muhammad Torequl Islam

Behavioural Brain Research · 2025

DOI: 10.1016/j.bbr.2024.115392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2025. Verfasst von Abdullah Al Shamsh Prottay und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh; Bioinformatics and Drug Inno…. Hauptthemen laut MEDLINE: Coumarins, Anxiety, Receptors, GABA-A, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Anxiety disorder is the most common mental illness and a major contributor to impairment. Thus, there is an urgent need to find novel lead compounds to mitigate anxiety. It is widely recognized that the neurobiology of anxiety-related behavior involves GABAergic systems. OBJECTIVES: This research aimed to examine the anxiogenic action of coumarin (CMN), a natural benzopyrone derived from plants, and determine its underlying mechanism through in vivo and in silico investigations. METHODS: This was accomplished by using a variety of behavioral procedures, including open field, swing, hole cross, and light-dark tests, on male and female Swiss albino mice that had been orally administered three experimental doses of CMN (1, 2, and 4 mg/kg). The CMN group was also examined with the GABAA receptor agonist diazepam (DZP, 2 mg/kg) and flumazenil antagonist (FLU, 0.1 mg/kg). Furthermore, CMN and standards were subjected to a molecular docking analysis to determine their binding affinities for the GABAA receptor subunits (α1, α4, β2, γ2, and δ). Several software programs were used to visualize the ligand-receptor interaction and analyze the pharmacokinetic profile. RESULTS: Compared to typical treatments, our results show that CMN (1 mg/kg) significantly (p < 0.05) increases the locomotor activity of animals. Furthermore, CMN exerted the highest binding affinity (-6.5 kcal/mol) with the GABA-α1 receptor compared to conventional DZP. Along with FLU, CMN displayed several hydrophobic and hydrogen bonds with GABAA receptor subunits. The pharmacokinetic and drug-like properties of CMN are also remarkable. In animal studies, CMN worked synergistically with FLU to provide anxiogenic-like effects. CONCLUSION: We conclude that, based on in vivo and in silico data, CMN, alone or in combination with FLU, may be employed in future neurological clinical studies. However, further research is needed to confirm this behavioral activity and elucidate the possible mechanism of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsAnxietyReceptors, GABA-AMolecular Docking SimulationDiazepamAnimalsMiceMaleFemaleAnti-Anxiety AgentsBehavior, AnimalFlumazenilComputer SimulationDisease Models, AnimalGABA-A Receptor Agonists

Stichwörter der Autor:innen

Anxiety disorderAnxiogenic effectCoumarinGABA(A) receptor subunits

Substanzen

CoumarinsReceptors, GABA-ADiazepamcoumarinAnti-Anxiety AgentsFlumazenilGABA-A Receptor Agonists

Autor:innen und Institutionen

  • Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh; Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj 8100, Ban…
  • Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh.
  • School of Pharmacy, Jeonbuk National University, Jeonju 54896, Republic of Korea.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil. Electronic address: hdmcoutinho@gmail.com.

Förderung

  • King Saud University

Zitieren

APA

Prottay, A. A. S., Emamuzzaman, Ripu, T. R., Sarwar, M. N., Rahman, T., Ahmmed, M. S., Bappi, M. H., Emon, M., Ansari, S. A., Coutinho, H. D. M., & Islam, M. T. (2025). Anxiogenic-like effects of coumarin, possibly through the GABAkine interaction pathway: Animal studies with in silico approaches. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.115392

Vancouver

Prottay AAS, Emamuzzaman, Ripu TR, Sarwar MN, Rahman T, Ahmmed MS, et al. Anxiogenic-like effects of coumarin, possibly through the GABAkine interaction pathway: Animal studies with in silico approaches. Behavioural Brain Research. 2025. doi:10.1016/j.bbr.2024.115392

BibTeX
@article{Prottay2025,
  author = {Prottay, Abdullah Al Shamsh and Emamuzzaman and Ripu, Tawfik Rakaiyat and Sarwar, Md Nazim and Rahman, Towfiqur and Ahmmed, Md Shakil and Bappi, Mehedi Hasan and Emon, Md and Ansari, Siddique Akber and Coutinho, Henrique D M and Islam, Muhammad Torequl},
  title = {Anxiogenic-like effects of coumarin, possibly through the GABAkine interaction pathway: Animal studies with in silico approaches},
  journal = {Behavioural Brain Research},
  year = {2025},
  doi = {10.1016/j.bbr.2024.115392}
}
Kostenlos starten →